CIAAT Co., Ltd. (XKON:103660)
South Korea · Delayed Price · Currency is KRW 1,999.00
+99.00 (5.21%)
At close: Jul 31, 2026
CIAAT Revenue
In the year 2014, CIAAT had annual revenue of 17.79B KRW with 36.03% growth.
Revenue
17.79B
Revenue Growth
+36.03%
P/S Ratio
0.68
Revenue / Employee
183.36M
Employees
97
Market Cap
12.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 17.79B | 4.71B | 36.03% |
| Dec 31, 2013 | 13.07B | 977.04M | 8.08% |
| Dec 31, 2012 | 12.10B | 6.28B | 108.06% |
| Dec 31, 2011 | 5.81B | -4.45B | -43.33% |
| Dec 31, 2010 | 10.26B | 1.65B | 19.19% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kwangdong Healthbio | 38.10B |
| Suntech.Co.,Ltd. | 17.88B |
| IK Semicon Co.,Ltd | 16.07B |
| Bioten | 10.71B |
| Curachem | 6.02B |
| TILON | 5.54B |
| TASCOM | 5.53B |
| EB Tech | 3.88B |